Many pharmacies in France no longer have an abortion pill on their shelves. The drug agency (ANSM) said Tuesday that it was informed of manufacturing delays for its specialty Gymiso.
In France, two specialties based on misoprostol are authorized in medical abortions and marketed by the Nordic Pharma laboratory, with largely American capital. The agency stresses that it has put in place a "quota" to better manage available stocks, and a ban on the sale and export of these drugs by wholesalers abroad.